As of 2026-01-21, the Relative Valuation of Exact Sciences Corp (EXAS) is (94.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 102.35 USD, the upside of Exact Sciences Corp based on Relative Valuation is -192.2%.
The range of the Relative Valuation is (92.95) - (104.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 20.1x | 17.3x |
| Forward P/E multiples | 17.9x - 20.4x | 19.0x |
| Fair Price | (92.95) - (104.50) | (94.36) |
| Upside | -190.8% - -202.1% | -192.2% |
| Date | P/E |
| 2026-01-20 | -19.69 |
| 2026-01-16 | -19.70 |
| 2026-01-15 | -19.69 |
| 2026-01-14 | -19.67 |
| 2026-01-13 | -19.67 |
| 2026-01-12 | -19.66 |
| 2026-01-09 | -19.64 |
| 2026-01-08 | -19.58 |
| 2026-01-07 | -19.55 |
| 2026-01-06 | -19.55 |
| 2026-01-05 | -19.54 |
| 2026-01-02 | -19.57 |
| 2025-12-31 | -19.54 |
| 2025-12-30 | -19.60 |
| 2025-12-29 | -19.61 |
| 2025-12-26 | -19.54 |
| 2025-12-24 | -19.53 |
| 2025-12-23 | -19.54 |
| 2025-12-22 | -19.59 |
| 2025-12-19 | -19.59 |
| 2025-12-18 | -19.50 |
| 2025-12-17 | -19.54 |
| 2025-12-16 | -19.57 |
| 2025-12-15 | -19.57 |
| 2025-12-12 | -19.52 |
| 2025-12-11 | -19.50 |
| 2025-12-10 | -19.48 |
| 2025-12-09 | -19.48 |
| 2025-12-08 | -19.42 |
| 2025-12-05 | -19.44 |
| 2025-12-04 | -19.45 |
| 2025-12-03 | -19.48 |
| 2025-12-02 | -19.47 |
| 2025-12-01 | -19.47 |
| 2025-11-28 | -19.48 |
| 2025-11-26 | -19.51 |
| 2025-11-25 | -19.45 |
| 2025-11-24 | -19.43 |
| 2025-11-21 | -19.41 |
| 2025-11-20 | -19.36 |
| 2025-11-19 | -16.58 |
| 2025-11-18 | -13.40 |
| 2025-11-17 | -12.92 |
| 2025-11-14 | -12.89 |
| 2025-11-13 | -13.03 |
| 2025-11-12 | -13.15 |
| 2025-11-11 | -12.98 |
| 2025-11-10 | -12.81 |
| 2025-11-07 | -12.73 |
| 2025-11-06 | -12.93 |